Singapore, June 20 -- During BIO International Convention in BostonUSA, theDepartment of Health -Abu Dhabi(DoH), the regulator of the healthcare sector inAbu Dhabi, and Abbott, the global healthcare leader, entered a landmark partnership to localise manufacturing of pharmaceuticals inAbu Dhabiand advance digital health solutions.

LeveragingAbu Dhabi'sadvanced life sciences infrastructure, this milestone reflects the emirate's proactive preparedness to reduce dependency on imports, strengthen supply chain resilience, and foster a sustainable, self-sufficient healthcare ecosystem.

The strategic collaboration outlines a comprehensive plan focusing on four key pillars including localisation of Abbott's pharmaceutical portfolio, biosimilar d...